Vermillion - 19 Year Stock Price History | VRML

Historical daily share price chart and data for Vermillion since 2000 adjusted for splits. The latest closing stock price for Vermillion as of July 19, 2019 is 0.78.
  • The all-time high Vermillion stock price is 357.50, which is 45733.3% above the current share price.
  • The Vermillion 52-week high stock price is 1.44, which is 84.6% above the current share price.
  • The Vermillion 52-week low stock price is 0.29, which is 62.8% below the current share price.
  • The average Vermillion stock price for the last 52 weeks is 0.79.
Vermillion Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.9884 0.3390 1.4400 0.3390 0.7762 158.73%
2018 0.9447 1.8000 1.8700 0.2900 0.3000 -84.46%
2017 1.6835 1.1000 2.6200 1.0900 1.9300 103.16%
2016 1.2973 1.7800 1.7899 0.8924 0.9500 -47.22%
2015 1.9465 1.9500 2.2700 1.6500 1.8000 -9.55%
2014 2.3778 2.5500 3.4000 1.2100 1.9900 -15.68%
2013 2.1501 1.3700 4.0400 1.0600 2.3600 78.79%
2012 1.7308 1.4500 3.0000 1.1800 1.3200 12.82%
2011 3.7975 6.8900 8.4400 1.0400 1.1700 -84.44%
2010 14.6295 25.8500 33.8100 4.7900 7.5200 -72.60%
2009 5.2285 0.3500 27.9900 0.0100 27.4500 10066.67%
2008 2.4174 7.5000 8.0000 0.2500 0.2700 -96.67%
2007 10.8610 10.1000 19.3000 6.5000 8.1000 -8.99%
2006 13.1625 11.3000 21.7000 8.4000 8.9000 -24.58%
2005 20.8468 41.3000 41.3000 8.6000 11.8000 -72.56%
2004 59.8119 84.1000 110.2000 26.9000 43.0000 -62.38%
2003 83.2639 34.2000 138.0000 32.9000 114.3000 231.30%
2002 44.6452 78.9000 78.9000 26.3000 34.5000 -56.88%
2001 56.1141 132.5000 132.5000 28.0000 80.0000 -39.62%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.079B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $117.486B 25.70
Intuitive Surgical (ISRG) United States $61.953B 54.10
Edwards Lifesciences (EW) United States $40.257B 40.22
IDEXX Laboratories (IDXX) United States $24.940B 65.43
Fresenius Medical Care AG KGaA (FMS) Germany $23.554B 15.48
Teleflex (TFX) United States $15.715B 34.05
Olympus (OCPNY) Japan $14.818B 110.87
SONOVA HOLDING (SONVY) Switzerland $14.646B 0.00
Sysmex ADR (SSMXY) Japan $14.258B 38.44
DexCom (DXCM) United States $13.966B 273.91
Hologic (HOLX) United States $13.000B 20.91
STERIS (STE) Ireland $12.503B 30.24
Varian Medical Systems (VAR) United States $12.310B 31.41
ABIOMED (ABMD) United States $11.899B 72.39
Masimo (MASI) United States $8.224B 50.39
Penumbra (PEN) United States $6.144B 260.09
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.087B 38.33
Integra LifeSciences Holdings (IART) United States $4.688B 22.03
Globus Medical (GMED) United States $4.267B 26.61
Tandem Diabetes Care (TNDM) United States $3.714B 0.00
LivaNova (LIVN) United Kingdom $3.587B 23.38
Wright Medical Group (WMGI) Netherlands $3.391B 672.25
Cantel Medical (CMD) United States $3.328B 33.77
Glaukos (GKOS) United States $2.775B 0.00
Integer Holdings (ITGR) United States $2.670B 19.67
Nihon Kohden (NHNKY) Japan $2.395B 24.10
Nevro (NVRO) United States $1.931B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.928B 30.51
Inogen (INGN) United States $1.312B 29.03
OPKO Health (OPK) United States $1.280B 0.00
Silk Road Medical (SILK) United States $1.268B 0.00
Veracyte (VCYT) United States $1.229B 0.00
CryoLife (CRY) United States $1.135B 112.63
Accelerate Diagnostics (AXDX) United States $1.023B 0.00
Tactile Systems Technology (TCMD) United States $1.022B 150.86
ORTHOFIX MEDICAL INC (OFIX) United States $0.977B 28.31
Luminex (LMNX) United States $0.906B 118.53
Pacific Biosciences Of California (PACB) United States $0.898B 0.00
ViewRay (VRAY) United States $0.894B 0.00
Natus Medical (BABY) United States $0.889B 20.59
Mesa Laboratories (MLAB) United States $0.877B 41.26
AngioDynamics (ANGO) United States $0.801B 26.26
Fluidigm (FLDM) United States $0.793B 0.00
AxoGen (AXGN) United States $0.784B 0.00
Quotient (QTNT) Switzerland $0.703B 0.00
Intersect ENT (XENT) United States $0.652B 0.00
Corindus Vascular Robotics (CVRS) United States $0.579B 0.00
OrthoPediatrics (KIDS) United States $0.525B 0.00
Si-Bone (SIBN) United States $0.496B 0.00
GenMark Diagnostics (GNMK) United States $0.353B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.349B 18.71
Accuray (ARAY) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.306B 60.64
RTI Surgical (RTIX) United States $0.302B 37.18
TransEnterix (TRXC) United States $0.296B 0.00
SeaSpine Holdings (SPNE) United States $0.242B 0.00
Neuronetics (STIM) United States $0.232B 0.00
Alphatec Holdings (ATEC) United States $0.217B 0.00
ConforMIS (CFMS) United States $0.217B 0.00
IRadimed (IRMD) United States $0.205B 39.13
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.170B 0.00
Second Sight Medical Products (EYES) United States $0.113B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Ekso Bionics Holdings (EKSO) United States $0.087B 0.00
EDAP TMS S.A (EDAP) France $0.079B 0.00
T2 Biosystems (TTOO) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Apollo Endosurgery (APEN) United States $0.067B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.054B 0.00